The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: Evidence-based Cardiology. 2013;(2): 16‑21

Read: 1052 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. Evidence-based Cardiology. 2013;(2):16‑21. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. Serruys P.W., de Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495.
  2. Grines C.L., Cox D.A., Stone G.W., et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999;341:1949-1956.
  3. Morice M.C., Serruys P.W., Sousa J.E., et al., RAVEL Study Group. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
  4. Carrozza J.P. Jr., Kuntz R.E., Levine M.J., et al. Angiographic and clinical outcome of intracoronary stenting: immediate and long- term results from a large single-center experience. J Am Coll Cardiol 1992;20:328-337.
  5. Holmes D.R. Jr., Leon M.B., Moses J.W., et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004;109:634-640.
  6. Lip G.Y., Huber K., Andreotti F., et al., Consensus Document of European Society of Cardiology Working Group on Thrombosis. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary - a consensus document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2010;31:1311-1318.
  7. Imazio M., Trinchero R., Brucato A., et al., COPPS Investigators. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J 2010;31:2749-2754.
  8. Deftereos S., Giannopoulos G., Kossyvakis C., et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol 2012;60:1790-1796.
  9. Sonoda S., Morino Y., Ako J., et al., SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol 2004;43:1959-1963.
  10. West N.E., Ruygrok P.N., Disco C.M., et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 2004;109:867-873.
  11. Strauss B.H. Diabetic patients receiving bare-metal stents: no option patients? J Am Coll Cardiol 2013;61:1686-1687.
  12. Levine G.N., Bates E.R., Blankenship J.C., et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention. J Am Coll Cardiol 2011;58:e44-122.
  13. Wijns W., Kolh P., Danchin N., et al. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio- Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-2555.
  14. Dans A.L., Connolly S.J., Wallentin L., et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation 2013;127:634-640.
  15. Kim B.-K., Hong M.-K., Shin D.-H., et al. A new strategy for discontinuation of dual antiplatelet therapy: the RESET trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol 2012;60:1340-1348.
  16. Witzenbichler B. Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins? J Am Coll Cardiol 2012;60:1349-1351.
  17. Natarajan M.K., Strauss B.H., Rokoss M., et al. Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. The STent Restenosis And Metabolism (STREAM) study. Cardiovasc Revasc Med 2012;13:95-100.
  18. Ali R.M., Degenhardt R., Zambahari R., et al. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention 2011;7 Suppl K:K83-92.
  19. Byrne R.A., Neumann F.J., Mehilli J., et al., the ISAR-DESIRE 3 investigators. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 2013;381:461-467.
  20. Woöhrle J., Zadura M., Moöbius-Winkler S., et al. SeQuent Please World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol 2012;60:1733-1738.
  21. O'Keefe J.H. Jr., McCallister B.D., Bateman T.M., et al. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 1992;19:1597-1600.
  22. Freed M., Safian R.D., O'Neill W.W., et al. Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995;76:1185-1188.
  23. Woudstra P., Damman P., Beijk M.A., et al. Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis. Catheter Cardiovasc Interv 2013;81:26-33.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.